↓ Skip to main content

Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma

Overview of attention for article published in Annals of Hematology, March 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
1 X user
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
14 Mendeley
Title
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma
Published in
Annals of Hematology, March 2019
DOI 10.1007/s00277-019-03645-7
Pubmed ID
Authors

Ryo Nakagawa, Yasushi Onishi, Akihisa Kawajiri, Koichi Onodera, Eijiro Furukawa, Sayaka Sano, Kei Saito, Satoshi Ichikawa, Tohru Fujiwara, Noriko Fukuhara, Hideo Harigae

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 29%
Student > Bachelor 2 14%
Student > Postgraduate 2 14%
Student > Ph. D. Student 2 14%
Other 1 7%
Other 2 14%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 6 43%
Biochemistry, Genetics and Molecular Biology 3 21%
Agricultural and Biological Sciences 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Physics and Astronomy 1 7%
Other 1 7%
Unknown 1 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2022.
All research outputs
#7,449,535
of 24,040,389 outputs
Outputs from Annals of Hematology
#423
of 2,291 outputs
Outputs of similar age
#136,028
of 358,085 outputs
Outputs of similar age from Annals of Hematology
#16
of 48 outputs
Altmetric has tracked 24,040,389 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 2,291 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.